Tumor cells are also sensitized to immune-mediated killing via the upregulation of death receptors, such as Fas and TRAIL receptors, that can interact with death ligands expressed or secreted by CTLs and NK cells [50,51]. This evidence concerns the gene FAS and neoplasm.